ADAR1 Capital Management »

Crescent Biopharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.2M 606k 11.86

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Deep Track Capital
Perceptive Advisors
Boxer Capital Management
Commodore Capital
Rtw Investments
Driehaus Capital Management

View all funds holding Crescent Biopharma